Healthcare Industry News: skin cancer
News Release - April 15, 2010
Fraxel re:store(R) Dual Laser Proven Effective in Treating Actinic Keratoses, a Common Precancerous Skin ConditionFraxel re:store Treatment Removes Actinic Keratoses and Improves the Overall Appearance of Skin
HAYWARD, Calif., April 15 -- (Healthcare Sales & Marketing Network) -- Solta Medical, Inc. (Nasdaq:SLTM ), a global leader in the medical aesthetics market and manufacturer of the industry's three premier brands: Thermage®, Fraxel®, and Isolaz®, today announced the new Fraxel re:store® DUAL laser system for the treatment of actinic keratoses (AK) – a precancerous skin condition caused by sun exposure. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin.
Fraxel re:store treatment provides superior results for AKs on the face or other areas of the body displaying the signs of photodamage. In an ongoing clinical study at the Laser & Skin Surgery Center of New York, dermatologists found that treatment with the new Fraxel re:store DUAL laser resolved 86% of AK lesions. In addition, the study found improvement in skin texture and pigmentation following a Fraxel treatment.
"skin cancer is one of the most preventable types of cancer, with sun protection and liberal use of a sunscreen of at least SPF 30," says Roy Geronemus, MD, director of the Laser & Skin Surgery Center of New York. "However, if one already has significant sun damage, as can be the case with active golfers, I recommend the new Fraxel re:store DUAL laser treatment. In our study, we found an 86% clearance of AKs after a series of treatments with the Fraxel re:store laser. This rate is comparable or better to other topical therapies; however Fraxel has the added benefit of improving skin quality, color and texture. I refer to the Fraxel re:store DUAL as the best of both worlds - removal of precancerous lesions as well as better looking skin."
To support skin cancer awareness, Solta Medical is sponsoring professional golf's Fresh Express Classic™ at TPC Stonebrae in northern California, which begins today. Tournament player Kyle Reifers is representing Fraxel in the competition and helping to raise awareness of the importance of sun protection. "On the golf course, I'm constantly exposed to the sun, but didn't really give a second thought to the damaging effects it might have on my skin," Reifers said. "Meeting with clinicians from Solta Medical, I now have a better understanding about what Fraxel can do to reverse sun damage and what I can do to prevent future damage from occurring while I'm out on the course."
"Solta Medical is committed to developing innovative, safe, and effective anti-aging solutions that deliver the best possible results in non-invasive aesthetic treatments," said Stephen J. Fanning, Chairman of the Board, President and CEO of Solta Medical, Inc. "The expanded versatility of the Fraxel re:store DUAL system demonstrates our commitment to provide physicians with the best technology to offer superior treatments for their patients."
As a sponsor of the Nationwide Tour's Fresh Express Classic™, Solta Medical will be offering onsite skin education and screenings at the tournament today through Sunday, April 18. For more information, visit www.freshexpressclassic.com.
ABOUT SOLTA MEDICAL, INC.
Solta Medical is a global leader in the medical aesthetics market providing innovative, safe, and effective anti-aging solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers products to address a range of skin issues under the industry's three premier brands: Thermage®, Fraxel® and Isolaz®. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. As the leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Isolaz is the only laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. Since 2002, approximately one million Thermage, Fraxel and Isolaz procedures have been performed in over 100 countries. For more information about Solta Medical, call 1-877-782-2286 or log on to www.solta.com.
The 1927 nm laser is not cleared for treatment of actinic keratoses.
© 2010 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Fraxel re:store, Isolaz and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.
Source: Solta Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.